melatonin has been researched along with memantine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (82.35) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cano-Abad, MF; de los Ríos, C; González-Lafuente, L; Lajarín-Cuesta, R; Martínez-Sanz, FJ; Moreno-Ortega, AJ; Punzón, E | 1 |
| Araujo de Brito, M; Arranz-Tagarro, JA; Arribas, RL; de Los Ríos, C; Gandía, L; González-Lafuente, L; Lajarín-Cuesta, R; Nanclares, C | 1 |
| Arribas, RL; de Los Ríos, C; Gandía, L; García-Frutos, EM; Lajarín-Cuesta, R; Nanclares, C | 1 |
| Kilic, E; Kilic, U; Reiter, RJ; Yilmaz, B; Yüksel, A | 1 |
| Hendren, RL | 1 |
| Ferriero, DM; Juul, SE | 1 |
| Farmer, M; Frydman-Marom, A; Fund, N; Harari, G; Laudon, M; Nir, T; Wade, AG; Zisapel, N | 1 |
| Beker, MC; Caglayan, AB; Caglayan, B; Gundogdu, RZ; Kelestemur, T; Kilic, E; Kilic, U; Yalcin, E; Yulug, B | 1 |
| Daulatzai, MA | 1 |
| Alagiakrishnan, K | 1 |
| Bardak, H; Bardak, Y; Uğuz, AC | 1 |
| Beniashvili, A; Jürgenson, M; Morozova, M; Noortoots, A; Zapolski, M; Zharkovskaja, T; Zharkovsky, A | 1 |
| Abbasinazari, M; Badri, T; Ghassab-Sahebkar, A; Keshvari, N; Qobadighadikolaei, R; Sarraf, N | 1 |
| Majidazar, R; Naseri, A; Rezazadeh-Gavgani, E; Sadigh-Eteghad, S | 1 |
| Andrade, C | 1 |
6 review(s) available for melatonin and memantine
| Article | Year |
|---|---|
Autism: biomedical complementary treatment approaches.
Topics: Acetylcysteine; Central Nervous System Depressants; Chelation Therapy; Child; Child Development Disorders, Pervasive; Complementary Therapies; Excitatory Amino Acid Antagonists; Fatty Acids, Omega-3; Humans; Immunoglobulins, Intravenous; Melatonin; Memantine; Micronutrients; Treatment Outcome; Vitamin B 12 | 2013 |
Pharmacologic neuroprotective strategies in neonatal brain injury.
Topics: Acetylcysteine; Allopurinol; Antioxidants; Ascorbic Acid; Biopterins; Erythropoietin; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Fructose; Humans; Hypoxia-Ischemia, Brain; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Melatonin; Memantine; Neuroprotective Agents; Nitric Oxide Synthase Type III; Resveratrol; Stilbenes; Topiramate; Vitamin E; Xenon | 2014 |
Pharmacotherpy and Alzheimer's Disease: The M-Drugs (Melatonin, Minocycline, Modafinil, and Memantine) Approach.
Topics: Alzheimer Disease; Animals; Benzhydryl Compounds; Cognitive Dysfunction; Humans; Melatonin; Memantine; Minocycline; Modafinil | 2016 |
Melatonin based therapies for delirium and dementia.
Topics: Aged; Animals; Antipsychotic Agents; Benzodiazepines; Chronobiology Phenomena; Clinical Trials as Topic; Delirium; Dementia; Drug Therapy, Combination; Galantamine; Humans; Indenes; Melatonin; Memantine; Neuroprotection; Practice Guidelines as Topic | 2016 |
Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews.
Topics: Alzheimer Disease; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Cholinesterase Inhibitors; Donepezil; Galantamine; Glycogen Synthase Kinase 3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Indans; Lithium; Melatonin; Memantine; Neurodegenerative Diseases; Rivastigmine; Systematic Reviews as Topic | 2022 |
Reconsideration of the Benefits of Pharmacological Interventions for the Attenuation of the Cognitive Adverse Effects of Electroconvulsive Therapy.
Topics: Calcium Channel Blockers; Cholinesterase Inhibitors; Cognition; Electroconvulsive Therapy; Humans; Hydrocortisone; Ketamine; Melatonin; Memantine; Narcotic Antagonists; Nortriptyline; Pemoline; Piracetam; Treatment Outcome; Triiodothyronine; Tryptophan | 2022 |
2 trial(s) available for melatonin and memantine
| Article | Year |
|---|---|
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Delayed-Action Preparations; Dopamine Agents; Drug Therapy, Combination; Female; Humans; Male; Melatonin; Memantine; Middle Aged; Placebos; Severity of Illness Index; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2014 |
Comparison of the efficacy and safety of melatonin and memantine in the alleviation of cognitive impairments induced by electroconvulsive therapy: A randomized clinical trial.
Topics: Adult; Aged; Cognition; Cognitive Dysfunction; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Male; Melatonin; Memantine; Middle Aged; Treatment Outcome | 2020 |
9 other study(ies) available for melatonin and memantine
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Neuroprotective profile of pyridothiazepines with blocking activity of the mitochondrial Na(+)/Ca(2+) exchanger.
Topics: Animals; Calcium; Cattle; Cell Line; Cell Line, Tumor; HeLa Cells; Hippocampus; Humans; Mitochondria; Neuroprotective Agents; Pyridines; Rats; Sodium-Calcium Exchanger; Solubility; Thiazepines | 2016 |
Gramine Derivatives Targeting Ca(2+) Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases.
Topics: Alkaloids; Animals; Calcium Channels; Cattle; Cell Survival; Dose-Response Relationship, Drug; Hippocampus; Humans; Indole Alkaloids; Molecular Structure; Neurodegenerative Diseases; Phosphoprotein Phosphatases; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tumor Cells, Cultured | 2016 |
Design and synthesis of multipotent 3-aminomethylindoles and 7-azaindoles with enhanced protein phosphatase 2A-activating profile and neuroprotection.
Topics: Aza Compounds; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Indoles; Molecular Structure; Neuroprotective Agents; Protein Phosphatase 2; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
Effects of memantine and melatonin on signal transduction pathways vascular leakage and brain injury after focal cerebral ischemia in mice.
Topics: Analysis of Variance; Animals; Cerebral Cortex; Cerebral Infarction; Corpus Striatum; Disease Models, Animal; DNA Fragmentation; Immunoglobulin G; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; MAP Kinase Signaling System; Melatonin; Memantine; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Phosphorylation; Signal Transduction | 2013 |
Targeting different pathophysiological events after traumatic brain injury in mice: Role of melatonin and memantine.
Topics: Animals; Brain; Brain Infarction; Brain Injuries; DNA Fragmentation; Free Radical Scavengers; Male; Melatonin; Memantine; Mice, Inbred BALB C; Neuroprotective Agents | 2016 |
Protective effects of melatonin and memantine in human retinal pigment epithelium (ARPE-19) cells against 2-ethylpyridine-induced oxidative stress: implications for age-related macular degeneration.
Topics: Apoptosis; Caspase 3; Caspase 9; Cell Line; Epithelial Cells; Glutathione; Glutathione Peroxidase; Humans; Macular Degeneration; Melatonin; Memantine; Membrane Potential, Mitochondrial; Oxidative Stress; Protective Agents; Pyridines; Reactive Oxygen Species; Retinal Pigment Epithelium; Vascular Endothelial Growth Factor A | 2018 |
Effects of the drug combination memantine and melatonin on impaired memory and brain neuronal deficits in an amyloid-predominant mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cholinesterase Inhibitors; Disease Models, Animal; Drug Combinations; Female; Male; Maze Learning; Melatonin; Memantine; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Peptide Fragments | 2019 |